USPTO Examiner BRAZIN JACQUELINE - Art Unit 1798

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19030771NUCLEIC ACID SEQUENCING SYSTEMJanuary 2025April 2025Allow300YesNo
18917940SYSTEMS, METHODS, AND APPARATUSES TO IMAGE A SAMPLE FOR BIOLOGICAL OR CHEMICAL ANALYSISOctober 2024February 2025Allow420YesNo
18887904NUCLEIC ACID SEQUENCING SYSTEMSeptember 2024May 2025Allow821YesNo
18784392MODULAR ASSAY SUPPORT DEVICESJuly 2024March 2025Allow711YesNo
18595902SOLID PHASE MICROEXTRACTION DEVICE AND METHOD FOR FORMINGMarch 2024October 2024Allow810YesNo
18586010SYSTEMS, METHODS, AND APPARATUSES TO IMAGE A SAMPLE FOR BIOLOGICAL OR CHEMICAL ANALYSISFebruary 2024August 2024Allow611YesNo
18288967NON-HEALTHCARE SETTING BIOLOGICAL TESTING SYSTEMOctober 2023January 2025Allow1410YesNo
18476837MICRO-BIOELECTROCHEMICAL CELL DEVICES AND METHODS OF DETECTING ELECTRON FLOWSSeptember 2023April 2025Allow1920NoNo
18464185OPTICAL MULTIANALYTE DETECTIONSeptember 2023December 2024Allow1521YesNo
18458544Flow CellAugust 2023April 2025Allow1920YesNo
18237677PACKAGING FOR MULTIPLEXED ASSAYSAugust 2023February 2025Allow1810YesNo
18450188DEVICE AND METHOD OF PORTABLE DRUG TESTINGAugust 2023September 2024Allow1320YesNo
18234317ASSAY USING SAMPLE THICKNESS MULTIPLEXINGAugust 2023February 2025Allow1820YesNo
18232405System for Deep Sediment Flow Culture Simulating In-situ Water PressureAugust 2023September 2024Abandon1410NoNo
18357610MODULAR ASSAY SUPPORT DEVICESJuly 2023July 2024Allow1111YesNo
18324445METHODS AND SYSTEMS FOR PROCESSING A NUCLEIC ACID SAMPLEMay 2023June 2025Allow2540YesNo
18137907SAMPLE COLLECTION DEVICEApril 2023January 2025Allow2130NoNo
18123492FILTER INSERT AND SAMPLE VIAL USING THE SAMEMarch 2023January 2025Allow2210NoNo
18148562PATHOGENIC MICROORGANISM SAMPLE COLLECTION AND PRESERVATION DEVICE WITH PROTECTION FUNCTIONDecember 2022March 2024Allow1420YesNo
18087499SYSTEMS AND METHODS FOR BIOCHEMICAL ANALYSIS INCLUDING A BASE INSTRUMENT AND A REMOVABLE CARTRIDGEDecember 2022August 2024Allow2011YesNo
18066666False Bottom Specimen Transport TubeDecember 2022December 2023Allow1220NoNo
17948804Kit and Device For Use With Gene Detection Techniques and TestingSeptember 2022September 2024Allow2431YesNo
17888396NASAL IRRIGATION DIAGNOSTIC ASSEMBLYAugust 2022December 2023Allow1610YesNo
17818144ROTARY PLATFORM FOR CELL LYSING AND PURIFICATION AND METHOD OF USEAugust 2022February 2023Allow610NoNo
17869645COVER MEMBER, METHOD AND TREATMENT MODULE FOR TREATING A BIOLOGICAL SAMPLE ON A SUBSTRATEJuly 2022July 2024Allow2421YesNo
17790955FLUID SYSTEM AND SAMPLE PROCESSOR INCLUDING FLUID SYSTEMJuly 2022May 2024Allow2221YesNo
17605842DETECTION METHOD AND DETECTION SYSTEM USING SUSPENSION LIQUID BIOCHIPJune 2022December 2024Allow3830YesNo
17831424SEMICONDUCTOR-BASED BIOSENSORS FOR BASE CALLINGJune 2022January 2024Allow2021YesNo
17824617DEVICES AND METHODS FOR EXTRACTING BLOOD PLASMAMay 2022March 2024Abandon2120NoNo
17715415LATERAL FLOW ASSAY WITH CONTROLLED CONJUGATE TIME AND CONTROLLED FLOW TIMEApril 2022March 2024Allow2310NoNo
17709213SYSTEM AND METHOD FOR DETECTING PATHOGENS IN AN ENVIRONMENT VIA AN ELECTROSTATIC AIR SAMPLERMarch 2022November 2022Allow810YesNo
17709310Kits for Stabilization of cfDNA in Urine SamplesMarch 2022January 2023Allow1020NoNo
17709348KITS FOR STABILIZING ANALYTES IN URINE SAMPLESMarch 2022February 2023Allow1140YesNo
17698011SENSOR ARRAYS WITH NUCLEOPHILIC INDICATORSMarch 2022September 2023Abandon1820NoNo
17655044IN VITRO DIAGNOSTIC SAMPLE TUBES AND METHODS OF USE THEREOFMarch 2022May 2023Abandon1421NoNo
17582244CELL COLLECTING APPARATUS, CELL COLLECTING METHOD, AND COMPUTER-READABLE MEDIUMJanuary 2022July 2025Abandon4110NoNo
17618037Oil Residue Protection in Oil-Encapsulated Digital MicrofluidicsDecember 2021June 2025Allow4220YesNo
17617881PLASMA SEPARATION AND SAMPLE METERING DEVICE AND KITS AND METHODS OF USE RELATED THERETODecember 2021February 2023Allow1430YesNo
17617153DUAL PORE SENSORSDecember 2021April 2025Abandon4010NoNo
17596247Automatic AnalyzerDecember 2021April 2025Allow4120NoNo
17596171INTERFACE FOR THE SYSTEM OF SAMPLING, PREPARATION, AND ANALYSIS OF A SAMPLE, ESPECIALLY BY CAPILLARY ELECTROPHORESISDecember 2021February 2025Abandon3910NoNo
17595802ROTARY PLATFORM FOR CELL LYSING AND PURIFICATION AND METHOD OF USENovember 2021July 2022Allow811YesNo
17455625GENOME EXTRACTION DEVICE INCLUDING SAFETY CLIP COMBINED WITH INNER CHAMBERNovember 2021April 2025Allow4110YesNo
17455554GENOME EXTRACTION DEVICE OF DUAL CHAMBER STRUCTURE IN WHICH OUTER CHAMBER AND INNER CHAMBER ARE COMBINED WITH EACH OTHERNovember 2021January 2025Allow3810YesNo
17606973RAPID PATHOLOGY/CYTOLOGY WITHOUT WASHOctober 2021December 2024Allow3850YesNo
17503086COMPACT OPTICAL VIRUS DETECTION ANALYZER OF NANO- AND MICRO- SIZE BIO PARTICLES USING LIGHT SCATTERING AND FLUORESCENCEOctober 2021May 2024Allow3160YesNo
17500029DROPPEROctober 2021March 2025Abandon4110NoNo
17498132WAFER FOR CARRYING BIOLOGICAL SAMPLEOctober 2021November 2022Allow1320YesNo
17492119Blood Sample Management Using Open Cell FoamOctober 2021March 2024Abandon3010NoNo
17488399DETECTION METHOD AND DETECTION DEVICESeptember 2021November 2024Allow3811YesNo
17441551METHOD FOR THE DETECTION AND QUANTIFICATION OF FOSFOMYCIN, IMPURITIES AND DEGRADATION PRODUCTS THEREOFSeptember 2021April 2025Allow4321NoNo
17471463COMPOUNDS FOR USE IN SYSTEM SUITABILITY TESTING OF INERT LC SYSTEMS AND COLUMNSSeptember 2021February 2023Allow1741YesNo
17434881PIPETTE TIP CONTAINING ONE OR MORE BARRIERSAugust 2021May 2023Allow2120YesNo
17405409Microfluidic Chip For Analysis Of Cell Motility And Methods For Using SameAugust 2021September 2024Allow3720NoNo
17394380Lateral Flow Assay Device for Detection of Analytes and Method of Detection ThereofAugust 2021January 2025Abandon4101NoNo
17424214PARTICLE CAPTURE DEVICE, PARTICLE CAPTURE METHOD, AND MICROSCOPE SYSTEMJuly 2021December 2024Abandon4101NoNo
17423448SPECIMEN SAMPLE COLLECTION DEVICE WITH BUFFER-CONTAINING CAPJuly 2021March 2023Allow2030YesNo
17421296DEVICE & METHOD FOR SALIVA-BASED ANALYTE TESTINGJuly 2021November 2024Allow4120YesNo
17419196CELL PROCESSING DEVICE CELL PROCESSING SYSTEM AND METHODS OF USE THEREOFJune 2021December 2024Abandon4110NoNo
17354669SPA/POOL WATER TREATMENT SYSTEM AND METHODJune 2021May 2023Allow2320YesNo
17354900METHODS FOR BONDING MOLECULES TO RUTHENIUM SURFACESJune 2021March 2025Abandon4411NoNo
17339891DEVICE AND METHOD FOR REPEATEDLY MODIFYING THE COMPOSITION OF A FLUIDJune 2021January 2024Allow3231YesNo
17335737NEEDLE-LESS ACCESS VIAL AND CAP FOR THE ASEPTIC SAMPLING AND STORAGE OF LIQUIDSJune 2021June 2024Allow3611YesNo
17332989LATERAL FLOW ASSAY WITH CONTROLLED CONJUGATE TIME AND CONTROLLED FLOW TIMEMay 2021November 2021Allow610YesNo
17296908SYSTEMS, DEVICES, AND METHODS FOR SEPARATING AND WASHING MICROORGANISMSMay 2021May 2025Allow4830YesNo
17323604SYRINGE-TYPE NUCLEIC ACID EXTRACTION APPARATUS, NUCLEIC ACID EXTRACTION KIT AND NUCLEIC ACID EXTRACTION METHOD THEREWITHMay 2021April 2023Abandon2301NoNo
17294041DECISION TREE POLYMERASE CHAIN REACTIONMay 2021November 2024Abandon4201NoNo
17308392SAMPLE AND REAGENT CONTAINERS WITH ANTI-VACUUM FEATUREMay 2021October 2023Allow2921YesNo
17244199FLUIDIC DEVICE AND METHOD FOR PREPARING A SAMPLE SUBSTRATEApril 2021May 2024Allow3621YesNo
17242749TFT-BASED CELL ISOLATION DEVICE AND CELL MANIPULATION PANEL THEREOFApril 2021February 2025Allow4621YesNo
17233222DROPPERApril 2021August 2021Allow410YesNo
17283977SYSTEMS AND METHODS FOR LOCALIZED SURFACE PLASMON RESONANCE BIOSENSINGApril 2021August 2024Allow4020NoNo
17282770New Apparatus and Methods for Disease Detection and TreatmentApril 2021July 2024Abandon3910NoNo
17220875SELF-ADMINISTERED INFECTION TESTING AND RESULT DETERMINATIONApril 2021September 2023Abandon2950YesNo
17213595EXTRACTION CELL FOR EXTRACTING A SAMPLEMarch 2021February 2024Allow3530YesNo
17278846INTEGRATED CARTRIDGEMarch 2021July 2024Abandon4010NoNo
17278647HEMOGLOBIN ASSAY REAGENT, ASSAY KIT AND ASSAY METHODMarch 2021May 2025Allow5040YesNo
17277958DIAGNOSTIC DEVICEMarch 2021June 2024Abandon3910NoNo
17203030APPARATUS AND METHOD FOR ANALYZING PLATELET AGGREGATIONMarch 2021April 2024Allow3721YesNo
17275328BIOCHEMICAL CARTRIDGE AND BIOCHEMICAL ANALYSIS DEVICEMarch 2021February 2025Allow4731YesNo
17270848PCR REACTION CONTAINERFebruary 2021March 2025Allow4920YesNo
17178918METHOD OF COLLECTING AND PRESERVING A BIOLOGICAL SAMPLEFebruary 2021September 2022Allow1920NoNo
17268975RAPID THERMAL CYCLING DEVICESFebruary 2021September 2024Abandon4320NoNo
17268685ASSAY USING SAMPLE THICKNESS MULTIPLEXINGFebruary 2021May 2023Allow2721NoNo
17174638SYSTEM FOR AUTOMATED PERMEATION OF A BIOLOGICAL MATERIAL AND METHOD OF USING SAMEFebruary 2021October 2023Allow3211YesNo
17172779PROGRAM FOR OPERATING CELL CULTURE SUPPORT APPARATUS, CELL CULTURE SUPPORT APPARATUS, AND METHOD FOR OPERATING CELL CULTURE SUPPORT APPARATUSFebruary 2021May 2025Allow5130YesNo
17265434PCR CARTRIDGEFebruary 2021September 2024Abandon4320YesNo
17162443DETECTION APPARATUS AND DETECTION METHODJanuary 2021April 2024Allow3841YesNo
17162034DEVICES AND METHODS FOR LASER CAPTURE MICRODISSECTIONJanuary 2021April 2024Allow3820NoNo
17264697NUCLEIC ACID AMPLIFICATION DEVICE HAVING A PLURALITY OF HEATING BLOCKSJanuary 2021October 2024Allow4520YesNo
17264669NUCLEIC ACID AMPLIFICATION DEVICE HAVING A PLURALITY OF HEATING BLOCKSJanuary 2021October 2024Abandon4520NoNo
17260372FIELD-FLOW FRACTIONATION DEVICEJanuary 2021July 2024Abandon4210NoNo
17259893THERMOCYCLER REACTION CONTROLJanuary 2021March 2025Abandon5020YesNo
17145954NANOSENSOR CHIP WITH COMPOUND NANOPORES AND METHODS OF USE THEREOFJanuary 2021July 2023Allow3040YesYes
17144387INTEGRATED CIRCUITS FOR NEUROTECHNOLOGY AND OTHER APPLICATIONSJanuary 2021July 2023Allow3010NoNo
17258864DEVICE, KIT AND METHODS FOR CREATING PLATELET RICH PLASMAJanuary 2021June 2023Allow2910YesNo
17247731STRUCTURED SUBSTRATES FOR IMPROVING DETECTION OF LIGHT EMISSIONS AND METHODS RELATING TO THE SAMEDecember 2020May 2022Allow1711NoNo
17123750System for Deep Sediment Flow Culture Simulating In-situ Water PressureDecember 2020September 2023Abandon3320NoNo
16973702DEVICE FOR GENERATING A DROPLET ARRAY, PREPARATION METHOD AND USE THEREOFDecember 2020December 2024Abandon4820NoNo
17114881Devices and Methods for Determining Impedance of Single Biological CellsDecember 2020May 2024Allow4131NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BRAZIN, JACQUELINE.

Strategic Value of Filing an Appeal

Total Appeal Filings
14
Allowed After Appeal Filing
5
(35.7%)
Not Allowed After Appeal Filing
9
(64.3%)
Filing Benefit Percentile
55.8%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 35.7% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner BRAZIN, JACQUELINE - Prosecution Strategy Guide

Executive Summary

Examiner BRAZIN, JACQUELINE works in Art Unit 1798 and has examined 474 patent applications in our dataset. With an allowance rate of 65.2%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 33 months.

Allowance Patterns

Examiner BRAZIN, JACQUELINE's allowance rate of 65.2% places them in the 18% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by BRAZIN, JACQUELINE receive 2.39 office actions before reaching final disposition. This places the examiner in the 82% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by BRAZIN, JACQUELINE is 33 months. This places the examiner in the 27% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +58.1% benefit to allowance rate for applications examined by BRAZIN, JACQUELINE. This interview benefit is in the 97% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 27.7% of applications are subsequently allowed. This success rate is in the 38% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 33.1% of cases where such amendments are filed. This entry rate is in the 41% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 160.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 90% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 87% percentile among all examiners. Of these withdrawals, 81.8% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 49.5% are granted (fully or in part). This grant rate is in the 59% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.2% of allowed cases (in the 51% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).

Quayle Actions: This examiner issues Ex Parte Quayle actions in 4.5% of allowed cases (in the 77% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.